Safety and Efficacy Study of Asfotase Alfa in Severely Affected Infants With Hypophosphatasia (HPP)



Status:Completed
Conditions:Endocrine
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:Any
Updated:4/3/2019
Start Date:September 2008
End Date:May 2010

Use our guide to learn which trials are right for you!

A Multicenter, Open-Label Study of the Safety, Tolerability and Pharmacology of Asfotase Alfa in up to 10 Severely Affected Patients With for the Treatment of Severely Affected Patients With Infantile Hypophosphatasia (HPP)

This clinical trial studies the safety and efficacy of asfotase alfa in infants and young
children with infantile onset HPP.

Hypophosphatasia (HPP) is a life-threatening, genetic, and ultra-rare metabolic disease
characterized by defective bone mineralization and impaired phosphate and calcium regulation
that can lead to progressive damage to multiple vital organs, including destruction and
deformity of bones, profound muscle weakness, seizures, impaired renal function, and
respiratory failure. There are no approved disease-modifying treatments for patients with
this disease. There is also limited data available on the natural course of this disease over
time, particularly in patients with the juvenile-onset form.

Inclusion Criteria:

- Legal guardian(s) must provide informed consent prior to any study procedures

- Documented diagnosis of severe HPP as indicated by:

- Total serum alkaline phosphatase at least 3 standard deviations (SD) below the
mean for age

- Plasma pyridoxal 5'-phosphate (PLP) at least 4 times the upper limit of normal

- Radiographic evidence of HPP (hypophosphatasia), characterized by:

- Flared and frayed metaphyses

- Severe, generalized osteopenia

- Widened growth plates

- One or more HPP-related findings:

- History or presence of:

- Non-traumatic post-natal fracture

- Delayed fracture healing

- History of elevated serum calcium

- Functional craniosynostosis with decreased head circumference growth

- Nephrocalcinosis

- Respiratory compromise

- Rachitic chest deformity and/or vitamin B6 dependent seizures

- Failure to thrive

- Onset of symptoms prior to 6 months of age

- Age ≤ 36 months

- Otherwise medically stable (patient may be on ventilatory support)

- Legal guardian(s) must be willing to comply with the study

Exclusion Criteria:

- History of sensitivity to any of the constituents of the study drug

- Current or prior clinically significant cardiovascular, endocrinologic, hematologic,
hepatic, immunologic, metabolic, infectious, urologic, pulmonary, neurologic,
dermatologic, renal condition and/or other major disease which, in the opinion of the
investigator, precludes study participation

- Treatment with an investigational drug within 1 month prior to the start of study drug
administration

- Current enrollment in any other study involving an investigational new drug, device or
treatment for HPP (e.g., bone marrow transplantation)

- Low serum calcium, phosphate or 25(OH) vitamin D

- Current evidence of a treatable form of rickets

- Prior treatment with bisphosphonate
We found this trial at
7
sites
2200 Children's Way
Nashville, Tennessee 37232
(615) 936-1000
Vanderbilt Children's Hospital Monroe Carell Jr. Children's Hospital at Vanderbilt is one of the nation's...
?
mi
from
Nashville, TN
Click here to add this to my saved trials
1600 Rockland Road
Wilmington, Delaware 19803
(302) 651-4200
Alfred I. duPont Hospital for Children Nemours began more than 70 years ago with the...
?
mi
from
Wilmington, DE
Click here to add this to my saved trials
Green Bay, Wisconsin 54301
?
mi
from
Green Bay, WI
Click here to add this to my saved trials
1 Children's Way
Little Rock, Arkansas 72202
(501) 364-1100
Arkansas Children's Hospital Arkansas Children's Hospital (ACH) is the only pediatric medical center in Arkansas...
?
mi
from
Little Rock, AR
Click here to add this to my saved trials
?
mi
from
Omaha, NE
Click here to add this to my saved trials
Springfield, Missouri 65804
?
mi
from
Springfield, MO
Click here to add this to my saved trials
?
mi
from
Winnipeg,
Click here to add this to my saved trials